Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07298135 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults

A NA study of Blood Glucose Control, sponsored by Olipop, PBC.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT07298135: Recruiting NA study of Blood Glucose Control, sponsored by Olipop, PBC.

NCT07298135 is a NA study of Blood Glucose Control that is actively recruiting participants, run by Olipop, PBC. The registered enrollment target is 224 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07298135, a NA study of Blood Glucose Control, is actively recruiting participants, sponsored by Olipop, PBC.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The main objective of this study is to evaluate the chronic effects of replacing traditional non-diet soda with a prebiotic soda on biomarkers associated with glycemic control in adults with glucose dysregulation who are habitual consumers of traditional soda.

Primary Outcome

Change in fasting plasma glucose

Conditions Studied

Interventions

  • BEHAVIORAL Active Control
  • BEHAVIORAL Prebiotic Soda

Study Locations (1)

Massachusetts

  • Lindus Health - Boston

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2025-12-17
Est. Completion 2026-05
Phase NA
Olipop, PBC

2 total trials

What NCT07298135 shows while recruiting

NCT07298135 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Blood Glucose Control appearing as the primary indexed condition, and to 2 interventions - of which Active Control is the first listed.

NCT07298135 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07298135 about?

NCT07298135 is a clinical study titled "A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults". The main objective of this study is to evaluate the chronic effects of replacing traditional non-diet soda with a prebiotic soda on biomarkers associated with glycemic control in adults with glucose dysregulation who are habitual consumers of traditional soda.

What is the current status of trial NCT07298135?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2025-12-17. Estimated completion is 2026-05.

What conditions does trial NCT07298135 study?

This clinical trial studies the following conditions: Blood Glucose Control.

What interventions are being tested in trial NCT07298135?

The interventions under investigation include: Active Control (BEHAVIORAL), Prebiotic Soda (BEHAVIORAL).

Who is sponsoring clinical trial NCT07298135?

This trial is sponsored by Olipop, PBC, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07298135 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07298135's enrollment target sits among peer trials

224 478th of 2000 higher than 1,520 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07298135, the US trial registry maintained by the National Library of Medicine. NCT07298135 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.